Tectonic Therapeutic management to participate in three investor conferences in September 2025.

Tectonic Therapeutic, a clinical stage biotechnology company, announced management participation in three investor conferences in September 2025. The conferences include the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, and Morgan Stanley 23rd Annual Global Healthcare Conference. The company's CFO, Chief Business Officer, and CEO will participate in fireside chats at these events.

Tectonic Therapeutic, a clinical-stage biotechnology company, has announced its participation in three major investor conferences in September 2025. The company, which specializes in GPCR-focused therapeutic proteins and antibodies, will be represented by its CFO, Chief Business Officer, and CEO at the following events:

1. Wells Fargo Healthcare Conference on September 3, featuring a fireside chat with CFO Daniel Lochner and CBO Marc Schwabish.
2. Cantor Global Healthcare Conference on September 4, with a fireside chat between CEO Alise Reicin and CFO Daniel Lochner.
3. Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, featuring a fireside chat with CEO Alise Reicin.

These live fireside chats will be available for replay on the company's website for approximately 90 days after the conferences. Additionally, the Tectonic management team will host one-on-one meetings during the three conferences. Interested investors are encouraged to contact their respective representatives at Wells Fargo, Cantor, and Morgan Stanley to schedule meetings.

Tectonic Therapeutic is headquartered in Watertown, Massachusetts, and focuses on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). The company leverages its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery) to develop biologic medicines that address significant unmet medical needs.

References:

[1] https://investors.tectonictx.com/stock-information
[2] https://www.stocktitan.net/news/TECX/tectonic-therapeutic-to-participate-in-september-investor-vt5xy84d7skj.html
[3] https://www.marketbeat.com/instant-alerts/filing-raymond-james-financial-inc-acquires-108668-shares-of-ssc-technologies-holdings-inc-ssnc-2025-08-21/